首页> 外国专利> Derivatives of 1-benzyl-5 - piperazin-1-yl - 3,4 Dihydro 1h quinazolin - 2 - One derivatives and their 1h benzo (1,2,6) thiadiazine - 2.2 - dioxides and 1,4 - dihydro - benzo (d) (1.3) - 2 - ona oxazines as 5-ht receptor modulators. For the treatment of Diseases of the central nervous system.

Derivatives of 1-benzyl-5 - piperazin-1-yl - 3,4 Dihydro 1h quinazolin - 2 - One derivatives and their 1h benzo (1,2,6) thiadiazine - 2.2 - dioxides and 1,4 - dihydro - benzo (d) (1.3) - 2 - ona oxazines as 5-ht receptor modulators. For the treatment of Diseases of the central nervous system.

机译:1-苄基5-哌嗪-1-基-3,4二氢1h喹唑啉-2-衍生物及其1h苯并(1,2,6)噻二嗪-2.2-二氧化物和1,4-二氢-苯并( d)(1.3)-2-恶嗪作为5-ht受体调节剂。用于治疗中枢神经系统疾病。

摘要

Acquisition methods, drug synthesis and use containing them. Item 1: a formula compound (1)Or a pharmaceutically acceptable salt, where y is C or s, M is C, M is m, y is C, y is m, y is s, n is 1 or 2, P is 0 to 3, q is 1 to 3, Z is r-o-so2,R is a number of 0-2, each RA and Rb is independent of each other, which is hydrogen or tar; X is ch or N; each R1, regardless of its appearance: halogenated; tar; halogenated tar; different tar; alcox; cyanogen; - S (o) s-rc; - C (= O) - ncrd; - s o 2-ncrd; - n (RC) - C (= O) - Rd; O-C (= O) RC; S is a quantity of 0-2, while RC and RD are independent, which are hydrogen or tar; R2 is an alternative arilo or alternative arilo; R2 is a preference for arilo, which is more inclined to optional phenyl, which is replaced by one or more trifluoro-1, halogenated-2, cyanogen, C1-6 tar or alcox C1-6; a This is - nr3-u-o, where R3 is: hydrogen, tar,ACIO, amidoal quilo, hydroxilquilo or alcohy; R3 is prior to hydrogen, alkyl or acyl fluoride; R4 and R5 are independent of each other and are hydrogen or tar, Or an R4 and R5 together with R3 and the atoms between them may form a ring of 3 to 7 rings, which may include a heterogeneous nitrogen or oxygen atom; and each independent R6, R7, R8, R9 and R10 are hydrogen or tar; or an R6 and R7 together with R10 and the atoms connected with them may form a single R10 and R7. Rings 3 to 7, or rings R5 and R7, together with the atoms to which they are attached, can form rings 3 to 7,Or R6 and R7 plus R8 and R9 and the atoms they connect to form a ring of 3 to 7 rings.
机译:获取方法,药物合成和包含它们的用途。第1项:式(1)或药学上可接受的盐,其中y为C或s,M为C,M为m,y为C,y为m,y为s,n为1或2,P为0至3,q为1至3,Z为ro-so2,R为0-2的数,每个RA和Rb彼此独立,为氢或焦油; X是ch或N;每个R1,无论其外观如何:卤化;柏油;卤化焦油不同的焦油酒精氰-S(o)s-rc; -C(= O)-ncrd; -s 2-ncrd; -n(RC)-C(= O)-Rd; O-C(= O)RC; S为0-2的量,而RC和RD独立,为氢或焦油; R 2是替代的arilo或替代的arilo; R 2是优选的芳基,其更倾向于任选的苯基,其被一个或多个三氟-1,卤代-2,氰,C1-6焦油或醇C1-6取代。 a这是-nr3-u-o,其中R3是:氢,焦油,ACIO,酰胺基quilo,hydroxilquilo或醇基; R3在氢,烷基或酰基氟之前; R 4和R 5彼此独立并且是氢或焦油,或者R 4和R 5与R 3以及它们之间的原子可以形成3至7个环的环,该环可以包括异质氮或氧原子;每个独立的R6,R7,R8,R9和R10为氢或焦油;或者R 6和R 7与R 10以及与它们连接的原子可以形成单个R 10和R 7。环3至7或环R5和R7与它们所连接的原子一起可以形成环3至7,或者R6和R7加R8和R9及其连接的原子形成3至7个环的环。

著录项

  • 公开/公告号AR047958A1

    专利类型

  • 公开/公告日2006-03-15

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG;

    申请/专利号AR2005P100106

  • 发明设计人 SUI MENG;ZHAO SHU-HAI;

    申请日2005-01-13

  • 分类号C07D239/80;C07D285/16;C07D265/22;C07D405/06;A61K31/517;A61K31/5415;A61K31/536;A61K31/343;A61P25/18;A61P25/28;A61P25/16;C07D307/81;C07D239/80;

  • 国家 AR

  • 入库时间 2022-08-21 21:40:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号